Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cherlene Y. Hardy"'
Autor:
Jerome T. Higgs, Joo Hyoung Lee, Hong Wang, Vishnu C. Ramani, Diptiman Chanda, Cherlene Y. Hardy, Ralph D. Sanderson, Selvarangan Ponnazhagan
Publikováno v:
Blood Advances, Vol 1, Iss 25, Pp 2375-2385 (2017)
Abstract: The current treatment options for multiple myeloma (MM) osteolytic lesions are mainly combinations of chemotherapy and other small-molecule inhibitors, but toxic side effects still remain a major concern. Studies have shown that osteoclast
Externí odkaz:
https://doaj.org/article/8b5854e28aa24631a1d2598960c4140b
Autor:
Cherlene Y. Hardy, Ralph D. Sanderson, Diptiman Chanda, Jerome T. Higgs, Joo Hyoung Lee, Selvarangan Ponnazhagan, Vishnu C. Ramani, Hong Wang
Publikováno v:
Blood Advances. 1:2375-2385
The current treatment options for multiple myeloma (MM) osteolytic lesions are mainly combinations of chemotherapy and other small-molecule inhibitors, but toxic side effects still remain a major concern. Studies have shown that osteoclast activity i
Autor:
Nirzari Gupta, Sooryanarayana Varambally, Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Prachi Bajpai, Cherlene Y. Hardy, Hyung-Gyoon Kim, Sai Akshaya Hodigere Balasubramanya, Sameer Al Diffalha, Sumit Agarwal, Amr Elkholy, Michael Behring, Upender Manne
Publikováno v:
Cancers
Cancers, Vol 12, Iss 4, p 772 (2020)
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 772 (2020)
Volume 12
Issue 4
The identification of colorectal cancer (CRC) molecular targets is needed for the development of drugs that improve patient survival. We investigated the functional role of phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succin